End-of-day quote
Other stock markets
|
||
- USD | - |
04-18 | Viatris' Proposed Femoston, Duphaston UK Rights Divestment Being Considered, CMA Says | MT |
04-18 | UK Regulator to Consider Undertakings for Theramex-Viatris Deal | MT |
Business Summary
Sales per Business
USD in Million | 2022 | Weight | 2023 | Weight | Delta |
---|---|---|---|---|---|
Brands
63.7
%
| 9,890 | 60.8 % | 9,801 | 63.7 % | -0.90% |
Generics
36.3
%
| 5,015 | 30.8 % | 5,588 | 36.3 % | +11.42% |
Sales per region
USD in Million | 2022 | Weight | 2023 | Weight | Delta |
---|---|---|---|---|---|
Developed Markets
37.0
%
| 5,844 | 35.9 % | 5,700 | 37.0 % | -2.46% |
United States
23.1
%
| 3,947 | 24.3 % | 3,552 | 23.1 % | -10.00% |
Emerging Markets
16.6
%
| 2,637 | 16.2 % | 2,552 | 16.6 % | -3.24% |
China
12.3
%
| 1,951 | 12.0 % | 1,889 | 12.3 % | -3.19% |
Japan, Australia and New Zealand
9.3
%
| 1,634 | 10.0 % | 1,425 | 9.3 % | -12.81% |
Greater China
1.8
%
| 250 | 1.5 % | 271 | 1.8 % | +8.60% |
Managers
Managers | Title | Age | Since |
---|---|---|---|
Scott Smith
CEO | Chief Executive Officer | 61 | 28/12/22 |
Abhijit Barve
CTO | Chief Tech/Sci/R&D Officer | - | - |
Chief Operating Officer | - | 15/11/20 | |
David Bayles
CMP | Compliance Officer | - | 15/11/20 |
Chief Tech/Sci/R&D Officer | - | - | |
Philippe Martin
CTO | Chief Tech/Sci/R&D Officer | - | 12-14 |
Rajiv Malik
BRD | Director/Board Member | 63 | 15/11/20 |
Investor Relations Contact | - | 31/10/20 | |
Bill Szablewski
IRO | Public Communications Contact | - | 15/11/20 |
Burt Park
LAW | General Counsel | - | - |
Members of the board
Members of the board | Title | Age | Since |
---|---|---|---|
Melina Higgins
CHM | Chairman | 56 | 15/11/20 |
Mark Parrish
BRD | Director/Board Member | 68 | 15/11/20 |
Harry Korman
BRD | Director/Board Member | 66 | 15/11/20 |
James Kilts
BRD | Director/Board Member | 76 | 15/11/20 |
Elisha Finney
BRD | Director/Board Member | 62 | 28/12/22 |
Robert Coury
BRD | Director/Board Member | 63 | 15/11/20 |
Rajiv Malik
BRD | Director/Board Member | 63 | 15/11/20 |
Scott Smith
CEO | Chief Executive Officer | 61 | 28/12/22 |
JoEllen Dillon
BRD | Director/Board Member | 60 | 15/11/20 |
Richard Mark
BRD | Director/Board Member | 70 | 15/11/20 |
Share class
Vote | Quantity | Free-Float | Company-owned shares | Total Float | |
---|---|---|---|---|---|
Stock A | 1 | 1,211,901,920 | 1,186,470,895 ( 97.90 %) | 21,239,521 ( 1.753 %) | 97.90 % |
Company contact information
Viatris, Inc.
Robert J. Coury Global Center 1000 Mylan Boulevard
15317, Canonsburg
+724 514 1800
http://www.viatris.comGroup companies
Name | Category and Sector |
---|---|
Utah Acquisition Sub, Inc.
| |
Biosimilars Newco Ltd.
Biosimilars Newco Ltd. Chemicals: SpecialtyProcess Industries Part of Viatris, Inc., Biosimilars Newco Ltd. is a British company that manufactures organic chemicals. The private company is located in the UK. |
Chemicals: Specialty
|
Sector
Sales per Business
Sales per region
1st Jan change | Capi. | |
---|---|---|
+29.68% | 699B | |
+25.07% | 571B | |
-4.35% | 364B | |
+17.65% | 326B | |
+3.77% | 286B | |
+14.68% | 236B | |
+4.71% | 198B | |
-12.43% | 194B | |
-3.79% | 154B |
- Stock Market
- Equities
- VTRS Stock
- Stock
- Company Mylan Inc